WHO ICTRP trial
Exploratory effect of long-term Verapamil therapy in adults with Type 1 diabetes…
ISRCTN49549481 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting
Key facts
| Trial ID | ISRCTN49549481 |
|---|---|
| Public title | Exploratory effect of long-term Verapamil therapy in adults with Type 1 diabetes mellitus (Ver-A-Long) |
| Scientific title | An open-label extension multi-centre trial in adult subjects diagnosed with Type 1 diabetes mellitus exploring the effect of long-term Verapamil SR therapy on the preservation of beta-cell function. |
| Primary sponsor | Medical University of Graz |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Austria;Belgium;England;France;Germany;Italy;Scotland;United Kingdom;Wales |
| Conditions | Type 1 Diabetes Nutritional, Metabolic, Endocrine |
| Interventions | The Ver-A-Long study involves a single treatment group receiving Verapamil SR, which is administered orally once daily. As this study involves only one treatment group, randomisation is not applicable. The treatment begins with a dose… |
| Registration date | Feb 24, 2025 |
| Target size | 30 |
| Secondary IDs | 2024-515234-33;Nil known;Nil known |
| Registry page | isrctn.com |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: